Hepatotoxicity from antithyroid drugs

Phase 4

Completed

• Conditions: Hyperthyroidism treated with antithyroid drugs; Hepatotoxicity, antithyroid drugs, Hyperthyroidism

• Registration Number: TCTR20180128001
• Lead Sponsor: one

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2017-04-29
• Study Start: 2018-01-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 149

Inclusion Criteria

1. Age more than 18 years old
2. Hyperthyroidism patient who treat with MMI or PTU

Exclusion Criteria

1. Abnormal liver function before treating hyperthyroidism
2. Abnormal liver function from other causes example viral hepatitis, ischemic hepatitis, autoimmune hepatitis

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Risk of hepatotoxicity from antithyroid drugs During treatment with antithyroid drugs Abnormal LFT during antithyroid drugs treatment

Secondary Outcome Measures

Name	Time	Method
/A N/A N/A